HIGHLIGHTS
- who: Anne S. De Groot et al. from the Institute for Immunology and Informatics, University of Rhode Island, Providence, RI, USA have published the research work: Tregitope Peptides: The Active Pharmaceutical Ingredient of IVIG?, in the Journal: (JOURNAL) of 12/07/2013
- what: In this brief report the authors provide an overview of the effects of Tregitopes in vivo discuss potential applications and suggest that Tregitopes may represent one of the "active pharmaceutical ingredients" of IVIg. This study demonstrated the feasibility of modulating CD8+ T-cell reactivity to an antigen using Tregitopes.
SUMMARY . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.